Virtu Financial’s Corvus Pharmaceuticals CRVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-16,038
| Closed | -$86K | – | 1474 |
|
|
2024
Q4 | $86K | Buy |
16,038
+344
| +2% | +$1.85K | ﹤0.01% | 1052 |
|
|
2024
Q3 | $83K | Buy |
+15,694
| New | +$83K | ﹤0.01% | 936 |
|
|
2024
Q2 | – | Sell |
-12,570
| Closed | -$22K | – | 1403 |
|
|
2024
Q1 | $22K | Buy |
+12,570
| New | +$22K | ﹤0.01% | 1153 |
|
|
2023
Q4 | – | Sell |
-17,366
| Closed | -$25K | – | 1635 |
|
|
2023
Q3 | $25K | Sell |
17,366
-8,176
| -32% | -$11.8K | ﹤0.01% | 978 |
|
|
2023
Q2 | $58K | Buy |
25,542
+6,188
| +32% | +$14.1K | ﹤0.01% | 1124 |
|
|
2023
Q1 | $18K | Buy |
19,354
+596
| +3% | +$554 | ﹤0.01% | 1260 |
|
|
2022
Q4 | $16K | Buy |
+18,758
| New | +$16K | ﹤0.01% | 1302 |
|
|
2022
Q2 | – | Sell |
-14,269
| Closed | -$23K | – | 1657 |
|
|
2022
Q1 | $23K | Buy |
+14,269
| New | +$23K | ﹤0.01% | 1274 |
|
|
2021
Q4 | – | Sell |
-19,688
| Closed | -$95K | – | 1791 |
|
|
2021
Q3 | $95K | Buy |
+19,688
| New | +$95K | 0.01% | 1158 |
|
|
2017
Q4 | – | Sell |
-10,205
| Closed | -$163K | – | 2432 |
|
|
2017
Q3 | $163K | Buy |
+10,205
| New | +$163K | 0.01% | 1934 |
|